An APRIL to remember: novel TNF ligands as therapeutic targets (original) (raw)

• Bodmer, J. L., Schneider, P. & Tschopp, J. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27, 19–26 (2002).
  Article CAS PubMed Google Scholar
• Hahne, M. et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 188, 1185–1190 (1998). The first publication describing the discovery of APRIL.
  Article CAS PubMed PubMed Central Google Scholar
• Shu, H. B., Hu, W. H. & Johnson, H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J. Leukoc. Biol. 65, 680–683 (1999).
  Article CAS PubMed Google Scholar
• Kelly, K., Manos, E., Jensen, G., Nadauld, L. & Jones, D. A. APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res. 60, 1021–1027 (2000).
  CAS PubMed Google Scholar
• Moore, P. A. et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285, 260–263 (1999).
  Article CAS PubMed Google Scholar
• Schneider, P. et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189, 1747–1756 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Mukhopadhyay, A., Ni, J., Zhai, Y., Yu, G. L. & Aggarwal, B. B. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J. Biol. Chem. 274, 15978–15981 (1999).
  Article CAS PubMed Google Scholar
• Gross, J. A. et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404, 995–999 (2000).
  Article CAS PubMed Google Scholar
• von Bulow, G. U. & Bram, R. J. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 278, 138–141 (1997).
  Article CAS PubMed Google Scholar
• Gras, M. P. et al. BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes. Int. Immunol. 7, 1093–1106 (1995).
  Article CAS PubMed Google Scholar
• Thompson, J. S. et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293, 2108–2111 (2001).
  Article CAS PubMed Google Scholar
• Yan, M. et al. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol. 11, 1547–1552 (2001).
  Article CAS PubMed Google Scholar
• Lentz, V. M., Hayes, C. E. & Cancro, M. P. Bcmd decreases the life span of B-2 but not B-1 cells in A/WySnJ mice. J. Immunol. 160, 3743–3747 (1998).
  CAS PubMed Google Scholar
• Ingold, K. et al. Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 201, 1375–1383 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Hendriks, J. et al. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ. 12, 637–648 (2005). References 14 and 15 describe the discovery that, in addition to binding TACI and BCMA, APRIL also binds to HSPG.
  Article CAS PubMed Google Scholar
• Roschke, V. et al. BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases. J. Immunol. 169, 4314–4321 (2002). The first publication describing the existence of BLyS/APRIL heterotrimers (HT) and demonstrating that HT are present at elevated levels in patients with various autoimmune diseases.
  Article CAS PubMed Google Scholar
• Kalled, S. L., Ambrose, C. & Hsu, Y. M. The biochemistry and biology of BAFF, APRIL and their receptors. Curr. Dir. Autoimmun. 8, 206–242 (2005).
  Article CAS PubMed Google Scholar
• Mackay, F., Sierro, F., Grey, S. T. & Gordon, T. P. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr. Dir. Autoimmun. 8, 243–265 (2005).
  Article CAS PubMed Google Scholar
• Kalled, S. L. The role of BAFF in immune function and implications for autoimmunity. Immunol. Rev. 204, 43–54 (2005).
  Article CAS PubMed Google Scholar
• Ng, L. G., Mackay, C. R. & Mackay, F. The BAFF/APRIL system: life beyond B lymphocytes. Mol. Immunol. 42, 763–772 (2005).
  Article CAS PubMed Google Scholar
• Schneider, P. The role of APRIL and BAFF in lymphocyte activation. Curr. Opin. Immunol. 17, 282–289 (2005).
  Article CAS PubMed Google Scholar
• Zola, H. et al. CD molecules 2005: human cell differentiation molecules. Blood (2005).
• Pradet-Balade, B. et al. An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. EMBO J. 21, 5711–5720 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Wallweber, H. J., Compaan, D. M., Starovasnik, M. A. & Hymowitz, S. G. The crystal structure of a proliferation-inducing ligand, APRIL. J. Mol. Biol. 343, 283–290 (2004).
  Article CAS PubMed Google Scholar
• Lopez-Fraga, M., Fernandez, R., Albar, J. P. & Hahne, M. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep. 2, 945–951 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Nardelli, B. et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97, 198–204 (2001).
  Article CAS PubMed Google Scholar
• Kolfschoten, G. M., Pradet-Balade, B., Hahne, M. & Medema, J. P. TWE-PRIL; a fusion protein of TWEAK and APRIL. Biochem. Pharmacol. 66, 1427–1432 (2003).
  Article CAS PubMed Google Scholar
• Yan, M. et al. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nature Immunol. 1, 37–41 (2000).
  Article CAS Google Scholar
• Marsters, S. A. et al. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr. Biol. 10, 785–788 (2000).
  Article CAS PubMed Google Scholar
• Wu, Y. et al. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J. Biol. Chem. 275, 35478–35485 (2000).
  Article CAS PubMed Google Scholar
• Yu, G. et al. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nature Immunol. 1, 252–256 (2000).
  Article CAS Google Scholar
• Liu, Y. et al. Ligand-receptor binding revealed by the TNF family member TALL-1. Nature 423, 49–56 (2003).
  Article CAS PubMed Google Scholar
• Hymowitz, S. G. et al. Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J. Biol. Chem. 280, 7218–7227 (2005).
  Article CAS PubMed Google Scholar
• Gordon, N. C. et al. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site. Biochemistry 42, 5977–5983 (2003).
  Article CAS PubMed Google Scholar
• Kim, H. M. et al. Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation. Nature Struct. Biol. 10, 342–348 (2003).
  Article CAS PubMed Google Scholar
• Patel, D. R. et al. Engineering an APRIL-specific B cell maturation antigen. J. Biol. Chem. 279, 16727–16735 (2004).
  Article CAS PubMed Google Scholar
• Mackay, F. & Ambrose, C. The TNF family members BAFF and APRIL: the growing complexity. Cytokine Growth Factor Rev. 14, 311–324 (2003).
  Article CAS PubMed Google Scholar
• Rennert, P. et al. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J. Exp. Med. 192, 1677–1184 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Schneider, P. et al. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187, 1205–1213 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Holler, N. et al. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol. Cell Biol. 23, 1428–1440 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Bishop, G. A. & Hostager, B. S. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev. 14, 297–309 (2003).
  Article CAS PubMed Google Scholar
• Couchman, J. R. Syndecans: proteoglycan regulators of cell-surface microdomains? Nature Rev. Mol. Cell Biol. 4, 926–937 (2003).
  Article CAS Google Scholar
• Day, E. S. et al. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry 44, 1919–1931 (2005).
  Article CAS PubMed Google Scholar
• Litinskiy, M. B. et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nature Immunol. 5, 822–829 (2002).
  Article CAS Google Scholar
• Craxton, A., Magaletti, D., Ryan, E. J. & Clark, E. A. Macrophage- and dendritic cell--dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101, 4464–4471 (2003).
  Article CAS PubMed Google Scholar
• Moreaux, J. et al. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 106, 1021–1030 (2005). These authors demonstrate that APRIL is produced by bone marrow stromal cells and osteoclasts, and discuss how this and other findings support a role for APRIL in normal plasma cell maintenance, and in multiple myeloma cell survival.
  Article CAS PubMed PubMed Central Google Scholar
• Ohata, J. et al. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J. Immunol. 174, 864–870 (2005).
  Article CAS PubMed Google Scholar
• Deshayes, F. et al. Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor. Oncogene 23, 3005–3012 (2004).
  Article CAS PubMed Google Scholar
• Novak, A. J., Bram, R. J., Kay, N. E. & Jelinek, D. F. Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood 100, 2973–2979 (2002). The first of many publications (including the following six references) demonstrating that malignant B cells aberrantly express BLyS and APRIL, and that inhibiting these ligands using soluble TACI-Ig or BCMA-Ig receptors or neutralizing mAbs can induce apoptosis of various tumor cells (multiple myeloma, CLL, NHL).
  Article CAS PubMed Google Scholar
• Kern, C. et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 103, 679–688 (2004).
  Article CAS PubMed Google Scholar
• Novak, A. J. et al. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood 104, 2247–2253 (2004).
  Article CAS PubMed Google Scholar
• Novak, A. J. et al. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood 103, 689–694 (2004).
  Article CAS PubMed Google Scholar
• He, B. et al. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J. Immunol. 172, 3268–3279 (2004).
  Article CAS PubMed Google Scholar
• Moreaux, J. et al. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 103, 3148–3157 (2004).
  Article CAS PubMed Google Scholar
• Nishio, M. et al. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α. Blood 106, 1012–1020 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Viau, M. & Zouali, M. B-lymphocytes, innate immunity, and autoimmunity. Clin. Immunol. 114, 17–26 (2005).
  Article CAS PubMed Google Scholar
• Ng, L. G. et al. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J. Immunol. 173, 807–817 (2004).
  Article CAS PubMed Google Scholar
• Laabi, Y. et al. The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed. Nucleic Acids Res. 22, 1147–1154 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Seyler, T. M. et al. BLyS and APRIL in rheumatoid arthritis. J. Clin. Invest. 115, 3083–3092 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Ye, Q. et al. BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses. Eur. J. Immunol. 34, 2750–2759 (2004).
  Article CAS PubMed Google Scholar
• Stein, J. V. et al. APRIL modulates B and T cell immunity. J. Clin. Invest. 109, 1587–1598 (2002). First publication describing the phenotype of APRIL transgenic mice.
  Article CAS PubMed PubMed Central Google Scholar
• Castigli, E. et al. Impaired IgA class switching in APRIL-deficient mice. Proc. Natl Acad. Sci. USA 101, 3903–3908 (2004). This and reference 68 describe APRIL deficient (knockout) mice.
  Article CAS PubMed Google Scholar
• Avery, D. T. et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 112, 286–297 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• O'Connor, B. P. et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199, 91–98 (2004). References 63 and 64 demonstrate a role for BLyS and APRIL in mediating plasmablast and plasma cell survival.
  Article CAS PubMed PubMed Central Google Scholar
• Yang, M. et al. B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells. J. Immunol. 175, 2814–2824 (2005).
  Article CAS PubMed Google Scholar
• Hatzoglou, A. et al. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-κB, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J. Immunol. 165, 1322–1330 (2000).
  Article CAS PubMed Google Scholar
• Bonci, D., Hahne, M., Felli, N., Peschle, C. & De Maria, R. Potential role of APRIL as autocrine growth factor for megakaryocytopoiesis. Blood 104, 3169–3172 (2004).
  Article CAS PubMed Google Scholar
• Varfolomeev, E. et al. APRIL-deficient mice have normal immune system development. Mol. Cell Biol. 24, 997–1006 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Planelles, L. et al. APRIL promotes B-1 cell-associated neoplasm. Cancer Cell 6, 399–408 (2004).
  Article CAS PubMed Google Scholar
• Gross, J. A. et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: impaired B cell maturation in mice lacking BLyS. Immunity 15, 289–302 (2001).
  Article CAS PubMed Google Scholar
• Schneider, P. et al. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J. Exp. Med. 194, 1691–1697 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• von Bulow, G. U., van Deursen, J. M. & Bram, R. J. Regulation of the T-independent humoral response by TACI. Immunity 14, 573–582 (2001).
  Article CAS PubMed Google Scholar
• Yan, M. et al. Activation and accumulation of B cells in TACI-deficient mice. Nature Immunol. 2, 638–643 (2001).
  Article CAS Google Scholar
• Seshasayee, D. et al. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18, 279–288 (2003).
  Article CAS PubMed Google Scholar
• Xu, S. & Lam, K. P. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol. Cell. Biol. 21, 4067–4074 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Schiemann, B. et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293, 2111–2114 (2001).
  Article CAS PubMed Google Scholar
• Shulga-Morskaya, S. et al. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J. Immunol. 173, 2331–2341 (2004).
  Article CAS PubMed Google Scholar
• Landers, C. D., Chelvarajan, R. L. & Bondada, S. The role of B cells and accessory cells in the neonatal response to TI-2 antigens. Immunol Res. 31, 25–36 (2005).
  Article CAS PubMed Google Scholar
• Castigli, E. et al. TACI and BAFF-R mediate isotype switching in B cells. J. Exp. Med. 201, 35–39 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Jabara, H. et al. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity 17, 265–276 (2002).
  Article CAS PubMed Google Scholar
• Koyama, T. et al. Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 64, 1065–1067 (2005). This paper, and many others listed below, demonstrate altered levels of APRIL and/or BLyS in various autoimmune disorders.
  Article CAS PubMed Google Scholar
• Stohl, W. et al. Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 63, 1096–1103 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Koyama, T. et al. A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus. Rheumatology (Oxford) 42, 980–985 (2003).
  Article CAS Google Scholar
• Ramanujam, M. et al. Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus. J. Immunol. 173, 3524–3534 (2004).
  Article CAS PubMed Google Scholar
• Odendahl, M. et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J. Immunol. 165, 5970–5979 (2000).
  Article CAS PubMed Google Scholar
• Tan, S. M. et al. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 48, 982–992 (2003).
  Article CAS PubMed Google Scholar
• Cheema, G. S., Roschke, V., Hilbert, D. M. & Stohl, W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 44, 1313–1319 (2001).
  Article CAS PubMed Google Scholar
• Wang, H. et al. TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nature Immunol. 2, 632–637 (2001).
  Article CAS Google Scholar
• Groom, J. et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest. 109, 59–68 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Mariette, X. et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann. Rheum. Dis. 62, 168–171 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Jonsson, M. V., Szodoray, P., Jellestad, S., Jonsson, R. & Skarstein, K. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome. J. Clin. Immunol. 25, 189–201 (2005).
  Article CAS PubMed Google Scholar
• Uccelli, A., Aloisi, F. & Pistoia, V. Unveiling the enigma of the CNS as a B-cell fostering environment. Trends Immunol. 26, 254–259 (2005).
  Article CAS PubMed Google Scholar
• Thangarajh, M. et al. Increased levels of APRIL (A Proliferation-Inducing Ligand) mRNA in multiple sclerosis. J. Neuroimmunol. 167, 210–214 (2005).
  Article CAS PubMed Google Scholar
• Thangarajh, M., Gomes, A., Masterman, T., Hillert, J. & Hjelmstrom, P. Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis. J. Neuroimmunol. 152, 183–190 (2004).
  Article CAS PubMed Google Scholar
• Salzer, U. et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nature Genet. 37, 820–828 (2005).
  Article CAS PubMed Google Scholar
• Castigli, E. et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nature Genet. 37, 829–834 (2005). References 95 and 96 describe mutations in TACI found in CVID and IgAD patients that lead to impaired APRIL binding and consequent inhibition of isotype switching.
  Article CAS PubMed Google Scholar
• Roth, W. et al. APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis. Cell Death Differ. 8, 403–410 (2001).
  Article CAS PubMed Google Scholar
• Okano, H. et al. Functional expression of a proliferation-related ligand in hepatocellular carcinoma and its implications for neovascularization. World J. Gastroenterol. 11, 4650–4654 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Craxton, A., Draves, K. E., Gruppi, A. & Clark, E. A. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J. Exp. Med. 202, 1363–1374 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Foger, N., Marhaba, R. & Zoller, M. Involvement of CD44 in cytoskeleton rearrangement and raft reorganization in T cells. J. Cell Sci. 114, 1169–1178 (2001).
  CAS Google Scholar
• Baker, K. P. et al. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis Rheum. 48, 3253–3265 (2003).
  Article CAS PubMed Google Scholar
• Pelletier, M. et al. Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF. J. Biol. Chem. 278, 33127–33133 (2003).
  Article CAS PubMed Google Scholar
• Ruben, S. M. Antibodies against tumor necrosis factor delta (APRIL). Patent. US 2003/0059862 A1 (2003).
• Kelley, R. F. & Patel, D. Variants of the extracellular domain of BCMA and uses thereof. Patent. WO 2005/075511 A1 (2005).